Specific Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 26-12-2024
- Paid Up Capital ₹ 0.41 M
as on 26-12-2024
- Company Age 35 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 64.17 Cr
as on 26-12-2024
- Revenue 93.06%
(FY 2021)
- Profit 187.80%
(FY 2021)
- Ebitda 11.39%
(FY 2021)
- Net Worth 22.10%
(FY 2021)
- Total Assets 23.86%
(FY 2021)
About Specific Laboratories
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.41 M.
The company has closed loans amounting to ₹64.17 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mohan Mulakala and Sujana Mulakala serve as directors at the Company.
- CIN/LLPIN
U24110TG1989PTC010678
- Company No.
010678
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Nov 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationSecunderabad, Telangana
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Specific Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Mulakala  | Managing Director | 17-Nov-1989 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sujana Mulakala | Director | 15-Sep-2010 | Current |
Financial Performance of Specific Laboratories.
Specific Laboratories Pvt. Ltd., for the financial year ended 2021, experienced significant growth in revenue, with a 93.06% increase. The company also saw a substantial improvement in profitability, with a 187.8% increase in profit. The company's net worth Soared by an impressive increase of 22.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Specific Laboratories?
In 2021, Specific Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sarvotham Solutions LimitedActive 11 years 6 monthsMohan Mulakala and Sujana Mulakala are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Standard Chartered Bank Creation Date: 17 Sep 2008 | ₹17.50 Cr | Satisfied |
State Bank Of India Creation Date: 09 May 2005 | ₹6.50 Cr | Satisfied |
State Bank Of India Creation Date: 15 Apr 2004 | ₹11.04 Cr | Satisfied |
How Many Employees Work at Specific Laboratories?
Unlock and access historical data on people associated with Specific Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Specific Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Specific Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
